Literature DB >> 24935465

Assessing validity of a depression screening instrument in the absence of a gold standard.

Bizu Gelaye1, Mahlet G Tadesse2, Michelle A Williams3, Jesse R Fann4, Ann Vander Stoep5, Xiao-Hua Andrew Zhou6.   

Abstract

PURPOSE: We evaluated the extent to which use of a hypothesized imperfect gold standard, the Composite International Diagnostic Interview (CIDI), biases the estimates of diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9). We also evaluate how statistical correction can be used to address this bias.
METHODS: The study was conducted among 926 adults where structured interviews were conducted to collect information about participants' current major depressive disorder using PHQ-9 and CIDI instruments. First, we evaluated the relative psychometric properties of PHQ-9 using CIDI as a gold standard. Next, we used a Bayesian latent class model to correct for the bias.
RESULTS: In comparison with CIDI, the relative sensitivity and specificity of the PHQ-9 for detecting major depressive disorder at a cut point of 10 or more were 53.1% (95% confidence interval: 45.4%-60.8%) and 77.5% (95% confidence interval, 74.5%-80.5%), respectively. Using a Bayesian latent class model to correct for the bias arising from the use of an imperfect gold standard increased the sensitivity and specificity of PHQ-9 to 79.8% (95% Bayesian credible interval, 64.9%-90.8%) and 79.1% (95% Bayesian credible interval, 74.7%-83.7%), respectively.
CONCLUSIONS: Our results provided evidence that assessing diagnostic validity of mental health screening instrument, where application of a gold standard might not be available, can be accomplished by using appropriate statistical methods.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bayesian analysis; Depression; Imperfect gold standard; Screening

Mesh:

Year:  2014        PMID: 24935465      PMCID: PMC4104527          DOI: 10.1016/j.annepidem.2014.04.009

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  25 in total

1.  Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests.

Authors:  N Dendukuri; L Joseph
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI).

Authors:  Ronald C Kessler; Jamie Abelson; Olga Demler; Javier I Escobar; Miriam Gibbon; Margaret E Guyer; Mary J Howes; Robert Jin; William A Vega; Ellen E Walters; Philip Wang; Alan Zaslavsky; Hui Zheng
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

Review 4.  SCAN. Schedules for Clinical Assessment in Neuropsychiatry.

Authors:  J K Wing; T Babor; T Brugha; J Burke; J E Cooper; R Giel; A Jablenski; D Regier; N Sartorius
Journal:  Arch Gen Psychiatry       Date:  1990-06

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 6.  New versions of World Health Organization instruments for the assessment of mental disorders.

Authors:  A Janca; T B Ustün; N Sartorius
Journal:  Acta Psychiatr Scand       Date:  1994-08       Impact factor: 6.392

7.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

8.  A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN).

Authors:  T S Brugha; R Jenkins; N Taub; H Meltzer; P E Bebbington
Journal:  Psychol Med       Date:  2001-08       Impact factor: 7.723

9.  Evaluation of diagnostic tests for the detection of classical swine fever in the field without a gold standard.

Authors:  A Bouma; J A Stegeman; B Engel; E P de Kluijver; A R Elbers; M C De Jong
Journal:  J Vet Diagn Invest       Date:  2001-09       Impact factor: 1.279

Review 10.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

Authors:  H U Wittchen
Journal:  J Psychiatr Res       Date:  1994 Jan-Feb       Impact factor: 4.791

View more
  9 in total

1.  Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial.

Authors:  Katherine E Watkins; Allison J Ober; Karen Lamp; Mimi Lind; Claude Setodji; Karen Chan Osilla; Sarah B Hunter; Colleen M McCullough; Kirsten Becker; Praise O Iyiewuare; Allison Diamant; Keith Heinzerling; Harold Alan Pincus
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

2.  Predictors of treatment initiation for alcohol use disorders in primary care.

Authors:  Katherine E Watkins; Allison Ober; Colleen McCullough; Claude Setodji; Karen Lamp; Mimi Lind; Sarah B Hunter; Karen Chan Osilla
Journal:  Drug Alcohol Depend       Date:  2018-07-24       Impact factor: 4.492

Review 3.  Diagnostic accuracy of the Whooley questions for the identification of depression: a diagnostic meta-analysis.

Authors:  Katharine Bosanquet; Della Bailey; Simon Gilbody; Melissa Harden; Laura Manea; Sarah Nutbrown; Dean McMillan
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

4.  Effects of surgical repair of obstetric fistula on severity of depression and anxiety in Ethiopia.

Authors:  Bekele Belayihun; Azwihangwisi Helen Mavhandu-Mudzusi
Journal:  BMC Psychiatry       Date:  2019-02-07       Impact factor: 3.630

5.  Accuracy of Self-Reported Items for the Screening of Depression in the General Population.

Authors:  Jorge Arias-de la Torre; Gemma Vilagut; Antoni Serrano-Blanco; Vicente Martín; Antonio José Molina; Jose M Valderas; Jordi Alonso
Journal:  Int J Environ Res Public Health       Date:  2020-10-29       Impact factor: 3.390

6.  Accuracy of Community Informant Led Detection of Maternal Depression in Rural Pakistan.

Authors:  Shamaila Mohsin; Ahmed Waqas; Najia Atif; Muhamamd Waqas Rabbani; Shahzad Ali Khan; Samina Bilal; Maria Sharif; Amina Bibi; Siham Sikander
Journal:  Int J Environ Res Public Health       Date:  2021-01-26       Impact factor: 3.390

7.  Trends in prevalence of depression and anxiety symptoms and effects of sociodemographic variables before and after the first wave of COVID-19 in Qatar.

Authors:  Salma M Khaled; Veena Davis; Iman Amro; Amal A M Ali; Peter W Woodruff; Peter M Haddad
Journal:  J Affect Disord       Date:  2022-04-09       Impact factor: 6.533

8.  The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.

Authors:  Allison J Ober; Cristina Murray-Krezan; Kimberly Page; Peter D Friedmann; Karen Chan Osilla; Stephen Ryzewicz; Sergio Huerta; Mia W Mazer; Isabel Leamon; Gabrielle Messineo; Katherine E Watkins; Teryl Nuckols; Itai Danovitch
Journal:  Addict Sci Clin Pract       Date:  2022-07-28

9.  Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia.

Authors:  Elmars Rancans; Marcis Trapencieris; Rolands Ivanovs; Jelena Vrublevska
Journal:  Ann Gen Psychiatry       Date:  2018-08-02       Impact factor: 3.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.